Physician profile
Ryan R Brooks
NPI 1205374683
$11,068.58
in general payments reported to CMS, 2019-2025
17 companies · $1,370 in 2025
The $1,370 reported for 2025 was more than what 79% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.31 · 2020: $21.31 · 2022: $5,230 · 2023: $987 · 2024: $3,432 · 2025: $1,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,451 · Travel and Lodging: $1,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,451.35 |
| Travel and Lodging | $1,337.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,183.60 | 2022-2025 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $2,843.78 | 2024-2025 | Evoke |
| Medtronic, INC. | $1,370.28 | 2022-2025 | Intellis Adaptivestim, Synchromedii |
| Relievant Medsystems, INC. | $510.61 | 2022 | |
| Valinor Pharma, LLC | $354.44 | 2024-2025 | Movantik |
| Nevro Corp. | $198.89 | 2024 | Senza |
| Abbvie INC. | $142.52 | 2022 | |
| Spr Therapeutics, INC | $119.94 | 2022-2025 | Sprint Pns System |
| Vertos Medical, INC. | $73.96 | 2023 | Mild Device Kit |
| Grt US Holding, INC. | $52.11 | 2022 | |
| Nalu Medical, INC. | $43.27 | 2025 | Nalu Neurostimulation System |
| Si-Bone, INC. | $40.48 | 2024 | |
| Stryker Corporation | $34.59 | 2025 | Vertaplex, Mild Device Kit, Ivas |
| Allergan, INC. | $33.08 | 2019-2020 | |
| Boston Scientific Corporation | $28.65 | 2025 | Intracept |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $21.84 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertical Pharmaceuticals, LLC | $16.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.